Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase II Trial to Explore Niraparib and Anlotinib Maintenance Retreatment in Platinum-Sensitive Recurrent Ovarian Cancer Patients Previously Treated With PARPi

Peking Union Medical College Hospital · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
epithelial ovarian cancer, platinum-sensitive recurrent ovarian cancer, maintanence retreatment, niraparib combined with anlotinib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 813784
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.